Top 10 Companies in the (S)-1-Phenylbutylamine (CAS 2033-60-4) Market (2026): Market Leaders Powering Global Synthesis

MARKET INSIGHTS

Global (S)-1-Phenylbutylamine (CAS 3789-60-4) market size was valued at USD 28.4 million in 2025. The market is projected to grow from USD 30.1 million in 2026 to USD 54.7 million by 2034, exhibiting a CAGR of 6.9% during the forecast period.

(S)-1-Phenylbutylamine (CAS 3789-60-4) is a chiral amine belonging to the class of optically active primary amines. As the (S)-enantiomer of 1‑phenylbutylamine, it is characterized by high optical purity and serves as a critical chiral building block and resolving agent in asymmetric synthesis. The compound finds application across pharmaceutical intermediates, agrochemical synthesis, and fine chemical manufacturing, where stereochemical precision is essential to end‑product efficacy and regulatory compliance.

The market is gaining steady traction, primarily driven by the expanding demand for enantioselective synthesis in pharmaceutical drug development and the growing emphasis on green chemistry principles that favor chiral resolution over racemic approaches. Increasing R&D investments in asymmetric catalysis and the rising adoption of chiral amines in the production of active pharmaceutical ingredients (APIs) continue to support market expansion. Key suppliers operating in this space include TCI Chemicals, Sigma‑Aldrich (Merck KGaA), and Alfa Aesar, among other specialty fine chemical manufacturers catering to global research and industrial demand.

(S)-1-Phenylbutylamine (CAS 2033-60-4) Market – View in Detailed Research Report

---

🔟 1. Solvias AG

Headquarters: Bischofszell, Switzerland
Key Offering: High‑purity chiral amines, catalytic resolution processes

Solvias AG has a long history of producing enantiomerically pure amines for the pharmaceutical and agrochemical sectors. Their proprietary asymmetric hydrogenation platform delivers high enantiomeric excess (ee) with low catalyst loading, ensuring cost‑effective supply for API intermediates.

Sustainability & Growth Initiatives:

• Investing in renewable feedstock for chiral synthesis
• Developing continuous flow reactors to reduce solvent usage
• Expanding contract manufacturing services for emerging markets

---

9️⃣ 2. BASF SE

Headquarters: Ludwigshafen, Germany
Key Offering: Advanced chiral chemistry, large‑scale production of specialty intermediates

BASF’s integrated platform combines chiral resolution, asymmetric catalysis, and downstream purification, enabling high‑yield production of (S)-1‑Phenylbutylamine for both pharmaceutical and fine chemical applications.

Sustainability & Growth Initiatives:

• Adopting green chemistry principles in catalyst design
• Implementing waste‑reduction protocols in resolution steps
• Collaborating with universities on biocatalytic enzyme engineering

---

8️⃣ 3. MilliporeSigma (Merck KGaA)

Headquarters: Darmstadt, Germany / USA
Key Offering: Research‑grade chiral reagents, analytical services

MilliporeSigma supplies high‑purity (S)-1‑Phenylbutylamine to academic and industrial laboratories, providing comprehensive HPLC and optical rotation data to support stereochemical validation.

Sustainability & Growth Initiatives:

• Offering eco‑friendly packaging solutions
• Providing digital tools for reaction monitoring and scale‑up
• Expanding global distribution network to emerging pharma hubs

---

7️⃣ 4. TCI Chemicals

Headquarters: Tokyo, Japan
Key Offering: Commercial‑grade chiral amines, custom synthesis

TCI Chemicals delivers cost‑effective (S)-1‑Phenylbutylamine for research and small‑scale production, with a strong focus on rapid turnaround for contract development and manufacturing organizations.

Sustainability & Growth Initiatives:

• Optimizing solvent selection for greener processes
• Investing in automated synthesis platforms
• Supporting local R&D collaborations in Asia‑Pacific

---

6️⃣ 5. Alfa Aesar

Headquarters: Haverhill, USA
Key Offering: Research‑grade chiral reagents, bulk supply

Alfa Aesar provides (S)-1‑Phenylbutylamine in both lab‑scale and bulk formats, catering to the needs of pharmaceutical development and fine chemical manufacturing.

Sustainability & Growth Initiatives:

• Implementing green solvent protocols
• Offering sustainability data sheets for each product
• Expanding e‑commerce platform for rapid procurement

---

5️⃣ 6. Jiangsu Aicksn Chemical Co., Ltd.

Headquarters: Nanjing, China
Key Offering: Large‑scale chiral amine production, cost‑competitive pricing

Jiangsu Aicksn specializes in scalable synthesis of (S)-1‑Phenylbutylamine, leveraging advanced catalytic processes to meet the growing demand from domestic and international pharmaceutical manufacturers.

Sustainability & Growth Initiatives:

• Adopting renewable energy sources for production facilities
• Implementing waste‑water recycling systems
• Partnering with local universities for talent development

---

4️⃣ 7. Hairui Chemical

Headquarters: Shenzhen, China
Key Offering: Research and industrial‑grade chiral intermediates

Hairui Chemical offers (S)-1‑Phenylbutylamine with strict quality controls, supporting both academic research and commercial API production.

Sustainability & Growth Initiatives:

• Investing in biocatalytic resolution technologies
• Reducing solvent consumption through process intensification
• Expanding export capabilities to Europe and North America

---

3️⃣ 8. Acros Organics (Thermo Fisher Scientific)

Headquarters: Waltham, USA / Belgium
Key Offering: High‑purity chiral reagents, analytical support

Acros Organics supplies (S)-1‑Phenylbutylamine with rigorous purity standards, complemented by detailed analytical data to facilitate regulatory submissions.

Sustainability & Growth Initiatives:

• Providing life‑cycle assessment reports for key products
• Developing greener catalytic systems
• Enhancing digital platforms for order management

---

2️⃣ 9. Tokyo Chemical Industry Co., Ltd. (TCI)

Headquarters: Tokyo, Japan
Key Offering: Custom synthesis, specialty chiral intermediates

TCI offers tailored synthesis of (S)-1‑Phenylbutylamine, enabling clients to optimize process conditions for specific API routes.

Sustainability & Growth Initiatives:

• Investing in renewable feedstock sourcing
• Implementing real‑time monitoring for process efficiency
• Expanding partnerships with contract development organizations

---

1️⃣ 10. Merck KGaA

Headquarters: Darmstadt, Germany
Key Offering: Comprehensive chiral chemistry solutions, API development

Merck KGaA provides (S)-1‑Phenylbutylamine as part of its extensive portfolio of chiral building blocks, supporting both small‑scale research and large‑scale industrial production.

Sustainability & Growth Initiatives:

• Developing low‑energy synthesis routes
• Reducing hazardous waste through green chemistry
• Expanding global supply chain resilience initiatives

---

Download FREE Sample Report: (S)-1-Phenylbutylamine (CAS 2033-60-4) Market – View in Detailed Research Report

Get Full Report: (S)-1-Phenylbutylamine (CAS 2033-60-4) Market – View in Detailed Research Report

---

🌍 Outlook: The Future of (S)-1-Phenylbutylamine Market

The market is poised for sustained growth driven by the global push for enantioselective drug development, regulatory emphasis on chiral purity, and the adoption of green chemistry principles. Emerging technologies in biocatalysis and continuous flow synthesis are expected to lower production costs and enhance scalability, creating new opportunities for both established and emerging players.

---

📈 Future Trends Shaping the Market

• Integration of AI‑driven process optimization for chiral synthesis
• Expansion of contract development and manufacturing services in Asia‑Pacific
• Increased regulatory scrutiny on precursor chemicals, driving demand for certified suppliers
• Growing focus on sustainability metrics in the supply chain, influencing purchasing decisions
• Development of novel chiral catalysts with lower metal loadings and higher turnover numbers